I suppose you mean, INFANTILE HEMANGIOMAS. Please use beta-blocker propranolol firstly 1-2 mg/kg. daily under the supervision of a pediatric cardiolog.

My colleagues  performed a prospective study of 34 cases of IH

treated with propranolol.

Beta blocker treatment was administered in 21 girls and 13

boys aged 2 to 14 months (mean age 5.4 months). All

patients were evaluated with electrocardiography and

echocardiography prior to start of treatment. Propranolol

was administrated at a dose of 1mg/kg/day divided in 3

equal parts (day 1) and 2mg/kg/day divided in 3 equal parts

(day 2), continuing with this dose throughout the rest of the

treatment. The treatment was initiated during a 24- 48 hours

hospitalization, time during which blood pressure and heart

rate were measured every 6 hours. After 24 hours of

hospitalization we performed an EKG and measured the

blood glucose level. None of our patients developed

hypotension, hypoglycemia or bronchospasm.

FOR MORE DETAILS SEE

http://www.jurnalulpediatrului.ro/pages/arhiva/61-62/61-62-05.pdf

Infantile haemangiomas are benign developmental vascular tumours that appear during the first months of life, and which characteristically have an initial proliferative and a later involutional phase.

Despite the good prognosis for spontaneous resolution of most infantile haemangiomas, there is no justification for therapeutic nihilism. The need for treatment of individual lesions should be carefully and sympathetically considered, and procrastination should be avoided because delay may severely reduce the opportunities for successful treatment.

Treatment options include: (i) systemic corticosteroids; (ii) intralesional corticosteroids; (iii) topical corticosteroids under occlusion; (iv) laser therapy; (v) compression; (vi) surgical excision; (vii) embolization; (viii) vincristine; (ix)

cryotherapy; (x) IFN-α-2a; (xi) sclerosant injection; and (xii) radiotherapy.

Intralesional injection of corticosteroids may effect rapid shrinkage, and is a very popular treatment for lesions of the eyelids. In general, two or three treatments are

required at approximately 6-week intervals. The failure rate is around 30%.